Applying population mechanistic modelling to find determinants of chimeric antigen receptor T-cells dynamics in month-one lymphoma patients

T CellsFurther Publications Immunology

Cardiovascular Events After Chimeric Antigen Receptor T-Cell Therapy for Advanced Hematologic Malignant Neoplasms: A Meta-Analysis

JAMA Netw Open

Koeckerling D, Reddy RK, Barker J, Eichhorn C, Divall P, Howard JP, Korell F, Schmitt M, Dreger P, Frey N, Lehmann LH

doi: 10.1001/jamanetworkopen.2024.37222

Further Publications Immunology

Haematopoietic stem cell transplant in cutaneous T-cell lymphomas: A multicentre propensity-score matched study

J Eur Acad Dermatol Venereol

Bejarano L, Grau-Pérez M, Paíno-Román M, Muret MPG, Morillo M, Muniesa C, Torre-Castro J, Estrach MT, Díez EA, Belloso RML, Peñate Y, Martínez-Mera C, Botella-Estrada R, Eceiza MJM, Ortiz Romero PL, Blanes M, Fernández-de-Misa R, Prieto-Torres L, Amer MEP, Iznardo H, Moreno-Vílchez C, Servitje O, García-Doval I, Cañueto J

doi: 10.1111/jdv.20638

Vitiligo

Autologous Cell Harvesting Device Provides Repigmentation and Improves Quality-of-Life for Patients with Stable Vitiligo Lesions in a Large and Diverse Patient Population: A pre-post study

J Am Acad Dermatol

Pandya AG, Mahmoud BH, Huggins RH, Ganesan AK, Silverberg NB, Munavalli G, Weiss E, Zubair R, Lal K, Jensen JD, Skelsey MK, Ezra N, Siperstein R, Noell C, Grekin SK, Hamzavi IH

doi: 10.1016/j.jaad.2025.03.066

Further Publications Immunology

Health-related quality of life in cutaneous T-cell lymphoma: A post hoc analysis of a phase 3 trial in mycosis fungoides and Sézary syndrome

J Eur Acad Dermatol Venereol

Ortiz Romero PL, Kim YH, Molloy K, Quaglino P, Scarisbrick J, Thornton S, Sandilands K, Dent JE, Nixon A, Williams A, Shinohara MM

doi: 10.1111/jdv.20357

Melanoma and Skin CancerImmunotherapy

Improved survival at the population level for patients with advanced Merkel cell carcinoma following availability of immunotherapy

J Am Acad Dermatol

Paulson KG, Park SY, Bhatia S, Hippe DS, Nghiem P

doi: 10.1016/j.jaad.2025.03.006

Melanoma and Skin Cancer

A multivariable disease specific model enhances prognostication beyond current Merkel cell carcinoma staging: an international cohort study of 10,958 patients

J Am Acad Dermatol

Andrew TW, Erdmann S, Alrawi M, Plummer R, Shalhout SZ, Sondak V, Brownell I, Lovat PE, Rose A

doi: 10.1016/j.jaad.2024.10.096

Melanoma and Skin Cancer

Survival outcomes and response to immune checkpoint inhibitors among patients with advanced Merkel cell carcinoma: a retrospective study of 81 patients

Ann Dermatol Venereol

David C, Coquelle C, Le Corre Y, L'Orphelin JM, Nardin C, Aubin F, Cassecuel J, Dreno B, Wierzbiecka-Hainault E, Bens G, Beneton N, Dinulescu M, Kervarrec T, Saiag P, Blom A, Samimi M

doi: 10.1016/j.annder.2025.103411

Melanoma and Skin Cancer

Do Large Language Model Chatbots perform better than established patient information resources in answering patient questions? A comparative study on melanoma

Br J Dermatol

Kamminga NC, Kievits JE, Plaisier PW, Burgers JS, van der Veldt AM, van den Brand JAGJ, Mulder M, Wakkee M, Lugtenberg M, Nijsten T

doi: 10.1093/bjd/ljae377

T Cells

BK Virus-Specific T Cell Response Associated with HLA Genotypes, RhD Status, and CMV or EBV Serostatus in Healthy Donors for Optimized Cell Therapy

J Clin Immunol

Mora-Buch R, Tomás-Marín M, Pasamar H, Enrich E, Peña-Gómez C, Rudilla F

doi: 10.1007/s10875-025-01901-2

Related content

Cardiovascular Events After Chimeric Antigen Receptor T-Cell Therapy for Advanced Hematologic Malignant Neoplasms: A Meta-Analysis

Haematopoietic stem cell transplant in cutaneous T-cell lymphomas: A multicentre propensity-score matched study

Autologous Cell Harvesting Device Provides Repigmentation and Improves Quality-of-Life for Patients with Stable Vitiligo Lesions in a Large and Diverse Patient Population: A pre-post study

Health-related quality of life in cutaneous T-cell lymphoma: A post hoc analysis of a phase 3 trial in mycosis fungoides and Sézary syndrome

Improved survival at the population level for patients with advanced Merkel cell carcinoma following availability of immunotherapy

A multivariable disease specific model enhances prognostication beyond current Merkel cell carcinoma staging: an international cohort study of 10,958 patients

Survival outcomes and response to immune checkpoint inhibitors among patients with advanced Merkel cell carcinoma: a retrospective study of 81 patients

Do Large Language Model Chatbots perform better than established patient information resources in answering patient questions? A comparative study on melanoma

BK Virus-Specific T Cell Response Associated with HLA Genotypes, RhD Status, and CMV or EBV Serostatus in Healthy Donors for Optimized Cell Therapy